0001415889-24-016065.txt : 20240607 0001415889-24-016065.hdr.sgml : 20240607 20240607182121 ACCESSION NUMBER: 0001415889-24-016065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fischer Laurent CENTRAL INDEX KEY: 0001379344 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 241031026 MAIL ADDRESS: STREET 1: C/O ADVERUM BIOTECHNOLOGIES, INC. STREET 2: 100 CARDINAL WAY CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-06072024_100617.xml X0508 4 2024-06-05 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001379344 Fischer Laurent C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300 FOSTER CITY CA 94404 true false false false 0 Stock Option (right to buy) 26.30 2024-06-05 4 A 0 8779 0 A 2034-06-04 Common Stock 8779 8779 D Deferred Stock Units 2024-06-05 4 A 0 5703 0 A Common Stock 5703 5703 D The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting. Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. /s/ Judit Ryvkin, Attorney-in-Fact 2024-06-07